Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Glutamine deprivation alters the origin and function of cancer cell exosomes.

Fan S-J. et al, (2020), EMBO J

Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].

Neal DE. et al, (2020), Eur Urol

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.

Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev

The effect of sample size on polygenic hazard models for prostate cancer.

Karunamuni RA. et al, (2020), Eur J Hum Genet

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Cappuccini F. et al, (2020), J Immunother Cancer, 8

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Sathianathen NJ. et al, (2020), Eur Urol

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.

Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.

Harrison S. et al, (2020), Cancer Causes Control, 31, 431 - 449

Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines).

Beard DJ. et al, (2020), Lancet, 395, 828 - 838

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

Neal DE. et al, (2020), Eur Urol, 77, 320 - 330

Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit- The "Fry-Turnbull" Effect.

Lovegrove CE. et al, (2020), BJU Int

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.

Bryant RJ. et al, (2020), BJU Int

Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis.

Rao SR. et al, (2020), Front Oncol, 10

Considerations and Methods for Placebo Controls in Surgical Trials: State of the Art Review and ASPIRE Guidance

BEARD DJ. et al, (2019), The Lancet

Mating induces switch from hormone-dependent to hormone-independent steroid receptor-mediated growth in Drosophila secondary cells.

Leiblich A. et al, (2019), PLoS Biol, 17

Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

Jiang X. et al, (2019), Nat Commun, 10

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.

Page EC. et al, (2019), Eur Urol

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Donovan JL. et al, (2019), J Clin Epidemiol, 113, 200 - 213

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants.

Wu L. et al, (2019), Cancer Res, 79, 3192 - 3204

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?